| 영문 | neurotransmitter | 한글 | 신경전달물질 |
|---|---|---|---|
| 설명 | 체내의 신경 세포에서 방출되며 인접하는 신경세포나 근육에 정보를 전달하는 물질. 신경세포내에서 합성되어서 신경종말의 연접소포에 저장된다. 자극에 의해서 연접간극에 유리되어서 수용체와 결합하여 정보를 다음 세포로 전한다. 전기적으로가 아니라 화학물질에 의해서 연접간극을 거쳐 정보를 전하기 때문에 화학전달물질이라고도 한다. 연접후막(경우에 따라서 연접전막)을 흥분(탈분극)시키는 흥분성전달물질과 억제(과분극)하는 억제성 전달물질이 있다. 아세틸콜린, 노르에피네프, 도파민, 글리신, γ-아미노뷰칠산(GABA)등 같은 신경전달물질이라도 수용체에 따라서 흥분성과 억제성으로도 작용하는 것도 있다. |
||
| 영문 | cholinergic | 한글 | 콜린(작동)성 |
|---|---|---|---|
| 설명 | 1.신경세포가 다른 신경세포로 정보를 전달할 경우에는 대부분 화학물질을 분비하여 그것을 매개로 하여 다른 신경에 정보를 전달한다. 이런 물질을 신경전달물질라고 한다. 콜린성이란 신경전달물질로 acetylcholine을 사용하는 신경을 이르는 말이다. 즉 부교감신경을 이르는 말로 쓰인다. 2. Acetylcholine과 유사한 약리적 작용을 하는. |
||
| NT, Nt | NeuroTransmitter |
|---|---|
| BNT | Boston Naming Test; brain neurotransmitter |
| CBF | Cholinergic basal forebrain |
|---|---|
| HCNP | Hippocampal cholinergic neurostimulating peptide |
| mAChR | Muscarinic cholinergic receptors |
| NANC | Non-adrenergic non-cholinergic |
| receptors, neurotransmitter | Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behaviour of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses. (12 Dec 1998) |
|---|---|
| peptide neurotransmitter | Small peptides used as primary or co transmitters in nerve cells for example FMRF amide, FLRFamide. (18 Nov 1997) |
| neurotransmitter | Any of a group of substances that are released on excitation from the axon terminal of a presynaptic neuron of the central or peripheral nervous system and travel across the synaptic cleft to either excite or inhibit the target cell. Among the many substances that have the properties of a neurotransmitter are acetylcholine, noradrenaline, adrenaline, dopamine, glycine, y aminobutyrate, glutamic acid, substance P, enkephalins, endorphins and serotonin. (18 Nov 1997) |
| neurotransmitter agents | Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (12 Dec 1998) |
| neurotransmitters and neurotransmitter agents | A collective grouping for neurotransmitters and substances that act on the neurotransmitter system. (12 Dec 1998) |
| neurotransmitter system | A group of nerve cells that use the sameneurotransmitter to communicate. (22 May 1997) |
| neurotransmitter uptake inhibitors | Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects. (12 Dec 1998) |
| receptors, cholinergic | Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behaviour of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. (12 Dec 1998) |
| cholinergic | <pharmacology> Resembling acetylcholine in pharmacological action, stimulated by or releasing acetylcholine or a related compound. (15 Jan 1998) |
| cholinergic agent | An agent that mimics the action of the parasympathetic nervous system (e.g., methacholine). (05 Mar 2000) |
| cholinergic agents | Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of acetylcholine, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of muscarinic agonist, although most modern texts discourage that usage. (12 Dec 1998) |
| cholinergic agonists | Drugs that bind to and activate cholinergic receptors. (12 Dec 1998) |
| cholinergic antagonists | Drugs that bind to but do not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists. (12 Dec 1998) |
| cholinergic blockade | Inhibition by a drug of nerve impulse transmission at autonomic ganglionic synapses (ganglionic blockade), at postganglionic parasympathetic effector cells (e.g., by atropine), and at myoneural junctions (myoneural blockade), the inhibition of a cholinergic agent. (05 Mar 2000) |
| cholinergic fibres | Nerve fibres liberating acetylcholine at the synapse after an impulse. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|